Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 3

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation

Authors Toniutto P, Fabris C, Bitetto D, Fornasiere E, Fumolo E, Rapetti R, Pirisi M

Published 6 June 2008 Volume 2008:4(3) Pages 599—603


Pierluigi Toniutto1, Carlo Fabris1, Davide Bitetto1, Ezio Fornasiere1, Elisa Fumolo1, Rachele Rapetti2, Mario Pirisi2

1Medical Liver Transplant Unit, DPMSC, Internal Medicine, University of Udine, Italy; 2Department of Clinical and Experimental Medicine (DiMeCS), University of Eastern Piedmont Amedeo Avogadro, Novara, Italy

Abstract: End stage liver disease due to hepatitis C virus (HCV) infection is the most common indication for liver transplantation (LT) worldwide. Regretfully, infection of the graft by HCV occurs almost universally after LT, causing chronic hepatitis and early progression to cirrhosis in a significant proportion of recipients. Moreover, graft and patient survival are significantly worse in patients undergoing LT for HCV-related cirrhosis than in those transplanted for other indications. Therefore, many LT centers consider antiviral treatment with interferon and ribavirin the mainstay of managing recurrent HCV disease in LT recipients. The optimal time to start treatment is unclear. In most instances, treatment is initiated when histological evidence of disease recurrence, either at protocol or on-demand liver biopsies, is observed after LT. However, antiviral treatment initiated before LT is a potential option for some patients for two reasons: first, clearing or suppressing HCV before LT may reduce or eliminate the risk of recurrent hepatitis C in the transplanted liver and thereby improve survival; second, clearing HCV in cirrhotic patient may halt disease progression and avoid the need for transplantation. In this article, the results obtained by pre-transplant antiviral regimens administered to HCV-positive cirrhotic patients awaiting LT are discussed.

Keywords: hepatitis C, antiviral therapy, liver cirrhosis, liver transplantation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Unusual case of contralateral Horner's syndrome following stellate-ganglion block: a case report and review of the literature

Amhaz HH, Manders L, Chidiac EJ, Pallekonda V, Chakrabortty S

Local and Regional Anesthesia 2013, 6:31-33

Published Date: 10 October 2013

Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer

Thérèse H Franco, Ahmed Khan, Vishal Joshi, Beje Thomas

Therapeutics and Clinical Risk Management 2008, 4:1367-1370

Published Date: 5 December 2008

Bowen’s disease – a review of newer treatment options

Thorsten Neubert, Percy Lehmann

Therapeutics and Clinical Risk Management 2008, 4:1085-1095

Published Date: 10 October 2008

Diagnosis with ECG-gated MDCT of floating thrombus in aortic arch in a patient with type-A dissection

Domenico Lumia, Gianpaolo Carrafiello, Domenico Laganà, Andrea Musazzi, Andrea Giorgianni, et al

Vascular Health and Risk Management 2008, 4:735-739

Published Date: 6 June 2008

Perioperative hypertension management

Joseph Varon, Paul E Marik

Vascular Health and Risk Management 2008, 4:615-627

Published Date: 6 June 2008

Effect of patient-specific factors on weekly warfarin dose

Heather P Whitley, Joli D Fermo, Elinor CG Chumney, Walter Adam Brzezinski

Therapeutics and Clinical Risk Management 2007, 3:499-504

Published Date: 15 July 2007

Detection and remediation of medically urgent situations using telemedicine case management for older patients with diabetes mellitus

Roberto Izquierdo, Suzanne Meyer, Justin Starren, Robin Goland, Jeanne Teresi, et al

Therapeutics and Clinical Risk Management 2007, 3:485-489

Published Date: 15 July 2007